<DOC>
	<DOCNO>NCT00000750</DOCNO>
	<brief_summary>Primary : To determine efficacy early treatment zidovudine ( AZT ) HIV-infected asymptomatic infant . To determine safety tolerance AZT patient population . Secondary : To compare virologic immunologic parameter treatment group . To determine efficacy AZT early treatment prevent development CD4+ cell depletion HIV-infected asymptomatic infant . AZT currently indicate primary treatment child HIV-associated sign symptom significant immunodeficiency . This study attempt determine whether early treatment AZT prevent development symptom HIV-infected infant asymptomatic .</brief_summary>
	<brief_title>A Phase III Study Evaluate Safety , Tolerance , Efficacy Early Treatment With Zidovudine ( AZT ) Asymptomatic Infants With HIV Infection</brief_title>
	<detailed_description>AZT currently indicate primary treatment child HIV-associated sign symptom significant immunodeficiency . This study attempt determine whether early treatment AZT prevent development symptom HIV-infected infant asymptomatic . Patients randomize receive oral AZT ( age-adjusted dos ) placebo . Patients evaluate week 2 4 every 4 week thereafter ; reach study endpoint treatment unblinded allow clinician determine treatment regimen patient receive . Patients meet criterion change open-label AZT give appropriate age-adjusted dose without unblinding original randomization assignment . Patients complete discontinue treatment follow every 6 month 2 year .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . CD4 count &gt; = 2000 cells/mm3 AND &gt; = 30 percent total lymphocyte . No sign symptom HIV infection ( lymphadenopathy , mild hepatomegaly , hypergammaglobulinemia , splenomegaly , permit ) . Consent parent guardian . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Serious acute infection require parenteral therapy time entry . One serious , proven bacterial infection include follow : septicemia ; pneumonia ; meningitis ; bone joint infection ; abscess internal organ body cavity ( exclude otitis medium superficial skin mucosal abscess ) cause Haemophilus , Streptococcus ( include pneumococcus ) , pyogenic bacteria . Clinical neurologic/neuropsychologic deficit , head circumference less fifth percentile . Concurrent Medication : Excluded : Any agent know antiretroviral activity . Acetaminophen , ibuprofen , aspirin 72 hour continuously . Prior Medication : Excluded : More 7 week prior antiretroviral immunomodulator therapy postnatally . Recommended : PCP prophylaxis . Immunizations accord current recommendation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>9 Months</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
</DOC>